ExLibris header image
SFX Logo
Title: Cancer: Metabolism in 'the driver's seat
Source:

Nature [0028-0836] Tasselli, L yr:2012


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Schulze, A. "How cancer metabolism is tuned for proliferation and vulnerable to disruption." Nature 491.7424 (2012): 364-373. Link to Full Text for this item Link to SFX for this item
2. Sancho Martinez, I. "Stem cells: Surf the waves of reprogramming." Nature 493.7432 (2013): 310-1. Link to Full Text for this item Link to SFX for this item
3. Weber, S. "Epigenetics: Erase for a new start." Nature 492.7429 (2012): 363-364. Link to Full Text for this item Link to SFX for this item
4. Birsoy, K. "MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors." Nature Genetics 45.1 (2012): 104-108. Link to SFX for this item
5. Wallace, Douglas C. "Mitochondria and cancer." Nature Reviews. Cancer 12.10 (2012): 685-698. Link to SFX for this item
6. Vander Heiden, Lewis G. "Understanding the Warburg effect: the metabolic requirements of cell proliferation." Science 324.5930 (2009): 1029-33. Link to SFX for this item
7. Finkelstein, J. "Metabolism and disease." Nature 491.7424 (2012): 347-347. Link to Full Text for this item Link to SFX for this item
8. Hsu, Peggy P P. "Cancer cell metabolism: warburg and beyond." Cell 134.5 (2008): 703-7. Link to SFX for this item
9. Trachootham, D. "Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?" Nature Reviews. Drug Discovery 8.7 (2009): 579-591. Link to Full Text for this item Link to SFX for this item
10. Dirks, Sheila K B. "Identification of human brain tumour initiating cells." Nature 432.7015 (2004): 396-401. Link to Full Text for this item Link to SFX for this item
11. Gramignoli, R. "Clinical Hepatocyte Transplantation: Practical Limits and Possible Solutions." European surgical research 54.3–4 (2015): 162-177. Link to SFX for this item
12. Khurana, E. "Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics." Science 342.6154 (2013): 1235587-1235587. Link to SFX for this item
13. Ganapathy, V. "The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function." Biochemical journal 450 (2013): 169-178. Link to SFX for this item
14. Farabegoli, F. "Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways." European journal of pharmaceutical sciences 47.4 (2012): 729-738. Link to SFX for this item
15. Guo, D. "A possible gene silencing mechanism: Hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells." Biochemical and biophysical research communications 428.1 (2012): 80-85. Link to SFX for this item
16. Brim, H. "SLC5A8 Gene, A Transporter of Butyrate: A Gut Flora Metabolite, Is Frequently Methylated in African American Colon Adenomas." PLoS ONE 6.6 (2011): 1-. Link to Full Text for this item Link to SFX for this item
17. Marx, V. "Epigenetics; Reading the second genomic code." Nature 491.7422 (2012): 143-147. Link to Full Text for this item Link to SFX for this item
18. Gifford, Casey A. "Epigenetic obstacles encountered by transcription factors: reprogramming against all odds." Current opinion in genetics & development 22.5 (2012): 409-415. Link to SFX for this item
19. Weitzman, J. "Epigenetics: Beyond face value." Nature 477.7366 (2011): 534-535. Link to Full Text for this item Link to SFX for this item
20. Friedrich Ben-Nun, Jeanne F. "Induced pluripotent stem cells from highly endangered species." Nature Methods 8.10 (2011): 805-807. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced